-
Electroconvulsive Therapy for Severe Refractory Tardive Dystonia Without Active Depression: A Case Report
-
Electroconvulsive Therapy: A Review of Its Current Status
-
An Unusual Case of Multifactorial Catatonia Following Taxane-Based Chemotherapy Regimen
-
Development of Bite Guards for Use in Electroconvulsive Therapy in Psychiatric Patients at Suanprung Psychiatric Hospital, Chiang Mai Province
-
Hydrogen Gas Therapy in Schizophrenia: Potential Neuroprotective Effects From an Animal Study
-
Managing Recurrent Postictal Worsening of Psychosis in Clozapine-Treated Schizophrenia: A Case Report
-
“Dream Insertion”: A Case Report of a Novel Psychotic Symptom in a Male Inpatient With Treatment Resistant Schizophrenia
-
Delusion of Jinn Possession in a Young Man With Schizophrenia: Case Report and Impact of Including a Religious Leader in Patient Care
-
A case of atypical neuroleptic malignant syndrome following depot antipsychotic withdrawal in ...
-
Association Between Frontotemporal Atrophy and Cognitive Impairment in Patients with Schizophrenia Based on Computed Tomography Imaging
-
Neuroleptic Malignant Syndrome: Review, Diagnostic Critique
-
Insights Into Subacute Combined Degeneration of the Cord: ‘Rabbit Ear Sign’ as a Radiodiagnostic Clue in Case of Vitamin B12 Deficiency Associated With Schizophrenia
-
Associations Between Serum Adipokine, Antipsychotic Exposure, and Clinical Characteristics in Chronic Schizophrenia: A Cross‐Sectional Study
-
Successful Clozapine Rechallenge in a 40-Year-Old Male Patient With Paranoid Schizophrenia After Clozapine-Associated Myocarditis
-
An excitement building in the development of psychological treatments for schizophrenia
-
A New Onset Paranoid Psychosis Associated With Fluoxetine and Bupropion: A Case Report
-
The new German evidence‐ and consensus‐based schizophrenia guideline
-
Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode Schizophrenia
-
Nuances of Gender Identity for a Transgender Patient Receiving Inpatient Treatment for Paranoid Schizophrenia: A Case Study
-
Biomarkers in Schizophrenia: Current Approaches and New Developments—A Literature Review
-
What does it take to make real‐world changes in schizophrenia care?
-
Towards an integrative and personalized care across the stages of schizophrenia spectrum disorders
-
Interventions in schizophrenia should be transdiagnostic, biologically informed, individualized, and disease modifying
-
The problem of recognition of clinical high‐risk states is hampering the prevention of schizophrenia
